Assessment of CD43 expression in adenoid cystic carcinomas, polymorphous low-grade adenocarcinomas, and monomorphic adenomas

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 102, Issue 4, 2006, Pages 495-500

  Woo, Victoria L ^a   Bhuiya, Tawfiqul ^b   Kelsch, Robert ^c  

^a New York Presbyterian Hospital   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c Division of Oral Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOSIALIN; TUMOR MARKER;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOMA; ADULT; AGED; ARTICLE; BIOSYNTHESIS; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; SALIVARY GLAND TUMOR;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD43; CARCINOMA, ADENOID CYSTIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748752121     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.08.038     Document Type: Article

References (21)

1. Pimenidou A., Madden L.A., Topping K.P., Smith K.A., Monson J.R.T., and Greenman J. Novel CD43 specific phage antibodies react with early stage colorectal tumours. Oncol Rep 11 (2004) 327-331
2. Cyster J.G., Shotton D.M., and Williams A.F. The dimensions of the lymphocyte-T glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J 10 (1991) 893-902
3. Cruz-Muñoz M.E., Salas-Vidal E., Salaiza-Suazo N., Becker I., Pedraza-Alva G., and Rosenstein Y. The CD43 coreceptor molecule recruits the zeta-chain as part of its signaling pathway. J Immunol 171 (2003) 1901-1908
4. Santana M.A., Pedraza-Alva G., Olivares-Zavaleta N., et al. CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, Nfkappa B transcription factors in human T lymphocytes. J Biol Chem 275 (2000) 31460-31468
5. Dibbern D.A., and Routes J.M. Wiskott-Aldrich Syndrome. EMedicine [serial on the Internet] (2004). http://www.emedicine.com/med/topic1162.htm Oct. Available from www.emedicine.com/med/topic1162.htm.
6. Lai R., Weiss L.M., Chang K.L., and Arber D.A. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. J Clin Pathol 3 (1999) 488-494
7. Shin J.S., Stopyra G.A., Warhol M.J., and Multhaupt H.A.B. Plasmacytoma with aberrant expression of myeloid markers, T-cell markers, and cytokeratin. J Histochem Cytochem 49 (2001) 791-792
8. Petruch U.R., Horny H.P., and Kaiserling E. Frequent expression of haemopoietic and non-haemopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue. Histopathology 20 (1992) 35-40
9. Baeckström D., Zhang K., Asker N., Ruetschi U., Ek M., and Hansson G.C. Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line. J Biol Chem 270 (1995) 13688-13692
10. Baeckström D. Post-translational fate of a mucin-like leukocyte sialoglycoprotein (CD43) aberrantly expressed in a colon carcinoma cell line. J Biol Chem 272 (1997) 11503-11509
11. Sikut R., Andersson D.X., Sikut A., Fernandez-Rodriguez J., Karlsson N.G., and Hansson G.C. Detection of CD43 (leukosialin) in colon adenoma and adenocarcinoma by novel monoclonal antibodies against its intracellular domain. Int J Cancer 82 (1999) 52-58
12. Ioachim H.L., Pambuccian S., Giancotti F., and Dorsett B. Reactivity of lung tumors with lung-derived and non-lung-derived monoclonal antibodies. Int J Cancer Suppl 8 (1994) 132-133
13. Seethala R.R., LiVolsi V.A., Pasha T.L., and Zhang P.J. CD43 expression in adenoid cystic carcinomas. [abstract]. Mod Pathol 17 (2004) 232A
14. Ellis B.L., and Auclair P.L. Tumors of the salivary glands. In: Ellis G.L., and Auclair P.L. (Eds). Atlas of Tumor Pathology. 3rd series (1995), Armed Forces Institute of Pathology, Washington, DC 203-216
15. Edwards P.C., Bhuiya T., and Kelsch R.D. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenoma. Oral Surg Oral Med Oral Pathol 97 (2004) 613-619
16. Ziprin P., Alkhamesi N.A., Ridgway P.F., Peck D.H., and Darzi A.W. Tumour-expressed CD43 (sialophorin) mediates tumour-mesothelial cell adhesion. Biol Chem 385 (2004) 755-761
17. Rosenstein Y., Park J.K., Hahn W.C., Rosen F.S., Bierer B.E., and Burakoff S.J. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 354 (1991) 233-235
18. Trian L. ICAM-5 (telencephalin)-a novel cell adhesion molecule [academic dissertation]. Available from http://ethesis.helsinki.fi/julkaisut/laa/biola/vk/tian/icam5tel.pdf.
19. Ziprin P., Ridgway P.F., Pfistermuller K.L., Peck D.H., and Darzi A. ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-a: a potential mechanism by which surgical trauma increases peritoneal metastases. Cell Commun Adhes 10 (2003) 141-154
20. Ardman B., Sikorski M.A., and Staunton D.E. CD43 interferes with T-lymphocyte adhesion. Proc Natl Acad Sci USA 89 (1992) 2001-2005
21. Maruya S.I., Myers J.N., Weber R.S., Rosenthal D.I., Lotan R., and El-Naggar A.K. Overexpression of ICAM-5 (Telencephalin) gene in head and neck squamous cell carcinoma: role in tumorigenesis and perineural invasion. [abstract]. Mod Pathol 18 (2005) 215A